The Comparative Trial of UFT + TAM With CMF + TAM in Adjuvant Therapy for Breast Cancer (CUBC)
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: UFT (uracil, tegafur) and tamoxifen|DRUG: CMF(cyclophosphamide, methotrexate, fluorouracil) and tamoxifen
Sponsor: Taiho Pharmaceutical Co., Ltd.